Evidence map›Paper›PMID 33870320›Full record

ArticleATS scholar2020

COVID-19 and the Early-Career Physician-Scientist. Fostering Resilience beyond the Pandemic.

Corrine R Kliment, Ian J Barbash, Jacob S Brenner, Divay Chandra, Katherine Courtright, Marc C Gauthier, Keven M Robinson, Leslie P Scheunemann, Faraaz A Shah, Jason D Christie and 1 more

Open access · goldAbstract read
In one paragraph

Article in ATS scholar, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Update in COVID-19 2020.American journal of respiratory and critical care medicine · 2021
    Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Corrine R KlimentDivision of Pulmonary, Allergy and Critical Care Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania.
Ian J BarbashDivision of Pulmonary, Allergy and Critical Care Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania.
Jacob S BrennerDivision of Pulmonary and Critical Care Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; and.
Divay ChandraDivision of Pulmonary, Allergy and Critical Care Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania.
Katherine CourtrightDivision of Pulmonary and Critical Care Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; and.
Marc C GauthierDivision of Pulmonary, Allergy and Critical Care Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania.
Keven M RobinsonDivision of Pulmonary, Allergy and Critical Care Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania.
Leslie P ScheunemannDivision of Pulmonary, Allergy and Critical Care Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania.
Faraaz A ShahDivision of Pulmonary, Allergy and Critical Care Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania.
Jason D ChristieDivision of Pulmonary and Critical Care Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; and.
Alison MorrisDivision of Pulmonary, Allergy and Critical Care Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania.
University of Pittsburgh · USUniversity of Pennsylvania · US

Funding

Role of FBXO24 mediated ubiquitination of FoxP1 protein in the pathogenesis and treatment of COPDR01HL153400 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI CHANDRA, DIVAY · 2020 to 2024
$2.3M
Nanomedicine for ARDS: A new paradigm to target drugs to multiple cell types within alveolar capillariesR01HL153510 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI BRENNER, JACOB · 2020 to 2024
$2.0M
The Role of Adenine Nucleotide Translocase in the Protection of Airway Epithelial Cells in Chronic Obstructive Pulmonary Disease (COPD)K08HL141595 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI KLIMENT, CORRINE R · 2018 to 2022
$813k
Nanonscale drug carriers for the treatment of acute respiratory distress syndromeK08HL138269 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI BRENNER, JACOB · 2017 to 2021
$746k
AHRQ HHS K08 HS027210NHLBI NIH HHS K08 HL138269NHLBI NIH HHS K08 HL141595NHLBI NIH HHS R01 HL153400NHLBI NIH HHS R01 HL153510
6 · The paper itself

Abstract

The coronavirus disease (COVID-19) pandemic has created significant stressors for the academic and scientific community, with unique challenges for early-career physician-scientists. The pandemic-related disruptions have significantly affected research productivity, access to mentoring, professional development and networking opportunities, funding, and personal wellness. This is especially true for pulmonary and critical care medicine faculty because of the burden of specialized clinical care responsibilities that the COVID-19 pandemic has demanded. Departmental, institutional, and national leadership should foster open dialogue to identify and mitigate these challenges to promote ongoing career development of early-career physician-scientists. Implementation of thoughtful interventions to address these challenges will provide essential support for junior faculty and help retain a generation of physician-scientists.

Indexed as

grant fundingmentoringprofessional developmentpulmonarywellness

Identifiers

PMID33870320
PMCPMC8043276
OpenAlexW3087554165

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.